Skip to content

Jazz Pharmaceuticals JAZZ Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Free cash flow margin30.4%-3.0pp33.4%+5.5pp27.9%-6.1pp34%+9.7pp
Efficiency
Asset turnover0.4×0.0×0.3×0.0×0.3×0.0×0.3×0.0×
Liquidity
Current ratio1.9×-2.6×4.5×+2.2×2.2×-0.6×2.8×-0.4×
Quick ratio1.7×-2.3×+2.1×1.8×-0.2×+0.1×
Cash ratio0.3×-2.0×2.3×+1.3×0.0×0.9×+0.2×
Leverage
Debt-to-equity1.3×-0.2×1.5×0.0×1.6×-0.3×1.9×+0.3×
Debt-to-assets0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×
Per Share
Book value per share$70.82+14.2%$62.02+19.6%$51.86+5.1%$49.34-25.7%
Valuation
Market capitalization$10.33B+38.8%$7.44B-3.3%$7.7B-23.3%$10.03B+28.1%
Enterprise value$15.07B+34.6%$11.2B-6.6%$11.99B-19.9%$14.97B+11.7%
Price / sales2.4×+0.6×1.8×-0.2×-0.7×2.7×+0.2×
Price / book2.4×+0.6×1.8×-0.2×2.1×-1.2×3.3×+1.3×
EV / sales3.5×+0.8×2.8×-0.4×3.1×-1.0×4.1×-0.2×
Free cash flow yield12.6%-5.7pp18.2%+4.4pp13.9%+1.5pp12.4%+2.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Jazz Pharmaceuticals's ratios come from?
Every ratio is computed from Jazz Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.